Hagel S, Pletz MW, Lehmann T. Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis. Author's reply. Intensive Care Med 2022 Mar 15. pii: 10.1007/s00134-022-06669.
PMID: 35292826